Spinal Cord InjuriesiSCINCT06971510
Exoskeleton Training on Balance Control and Turning in Ambulation in Individuals With Incomplete Spinal Cord Injury
A study testing Exoskeleton Training and Conventional Physical Therapy in people with Spinal Cord Injuries, run by Hong Kong Metropolitan University at 3 sites in China.
Trial summary
This study investigates the impact of exoskeleton training on individuals with incomplete spinal cord injury (iSCI). Investigators focus on assessing how the use of the exoskeleton influences balance control and turning during ambulation and quality of life in this population. Read more about this study
- Who is it for?
- Ages 18 to 65 yearsHealthy volunteers can take part
- Conditions the study is for
- Spinal Cord Injuries
- What is being tested?
- Exoskeleton Training and Conventional Physical Therapy
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 32 participants
- Where
- 3 sitesChina
- Study dates
- 1 Jun 2024to 30 Nov 2025
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Aged 18-65 years
- Traumatic or non-traumatic SCI, > 6 months since SCI onset Motor incomplete SCI (American Spinal Injury Association Impairment Scale, AIS C and D), neurologic level of injury (NLI) between C1-L2 (inclusive), as determined by the International Standards for Neurological Classification of SCI (ISNCSCI)
- Able to walk with or without walking aid independently for at least 2 meters
- No current or history of other neurological conditions
- Community-dwelling or living in a rehabilitation facility
- Medically stable for full weight-bearing locomotor training including 15-minute standing frame trial to assess standing tolerance
Show all 12Show fewer
- Weigh 220 pounds (100 kg) or less (exoskeleton equipment requirement)
- Between approximately 1.5 m and 1.9 m (5'0" and 6'4") tall (exoskeleton equipment requirement)
- Standing hip width of approximately 45 cm (18") or less (exoskeleton equipment requirement)
- Sufficient range of motion (ROM) to achieve a normal, reciprocal gait pattern, and normal sit-to-stand transitions.
- Hip extension greater than or equal to 5-degree Knee extension greater than or equal to 5-degree Ankle dorsiflexion greater than or equal to 0-degree
- Sufficient upper extremity strength to use a front wheeled walker by manual muscle testing (minimum triceps strength bilaterally of 3/5 of Oxford Scale, shoulder abduction and flexion/extension 4/5 of Oxford Scale)
Who cannot join
- AIS-A SCI or AIS-B SCI
- Have been trained in exoskeleton or other robotic device for locomotor training within the past 4 months except for one or two training/demonstration sessions
- Currently involved in another intervention study
- Any medical issue that precludes full weight-bearing locomotor training including but not limited to:
- Spinal instability (or spinal orthotic unless cleared by physician) Acute deep vein thrombosis (DVT) with activity restrictions Severe, recurrent autonomic dysreflexia (AD) requiring medical intervention Heterotopic ossification (HO) in the lower extremities resulting in ROM restrictions at the hips or knees Two or more pathological fractures in the last 48 months in a major weight-bearing bone (femur or tibia) in the lower extremity Hip subluxation (x-rays will be obtained for individuals injured prior to 10 years of age)
- Any medical issue that would affect participant safety either due to cognitive deficits/impulsivity, intolerance to mild exercise, or other factors
Show all 11Show fewer
- Any issue that would confound results such as a concurrent neurological injury or disorder (other than SCI) or other factors
- Skin integrity issues in areas that contact the device (including abdominal ostomies) or that would prohibit sitting
- Pregnancy
- Participants who do not meet the exoskeleton equipment requirements
- Modified Ashworth Scale (MAS) = 4 in the majority of lower extremity joints (e.g. greater than or equal to four joint movements in bilateral lower extremities when testing hip flexion/extension, knee flexion/extension, ankle dorsi/plantar flexion)
Trial locations and contacts
3 sites in 1 country.
China3 sites
Changzhou Sunshine Rehabilitation hospital
Changzhou, Jiangsu, 213022
Hong Kong Metropolitan University
Hong Kong, 999077
Rehabilitation Medicine Department, The Affiliated BenQ Hospital of Nanjing Medical University
Nanjing, Jiangsu, 210019
About this study
Official title: The Effectiveness of Robotic Exoskeleton on Sensori-motor Performance in Subjects With Incomplete Spinal Cord Injury: A Functional Near-Infrared Spectroscopy Study
This study investigates the impact of exoskeleton training on individuals with incomplete spinal cord injury (iSCI). Investigators focus on assessing how the use of the exoskeleton influences balance control and turning during ambulation and quality of life in this population. The study mainly involves interventions with participants utilizing exoskeleton devices to explore the influence on mobility, stability, and neuroplasticity, providing new insights into the potential benefits of exoskeleton training for individuals with incomplete spinal cord injuries.
Read the detailed description
Spinal cord injury (SCI) poses profound challenges to individuals, disrupting complex neural pathways responsible for motor and sensory functions. Across a spectrum of impairments, the ability to navigate and maneuver during walking, particularly turning, is a significant obstacle for patients with incomplete SCI (iSCI). Despite advances in rehabilitation strategies, turning-while-walking remains a biomechanically demanding task that is often overlooked in traditional interventions that focus primarily on linear gait training.
Turning-while-walking requires coordinated movements of the head, trunk, pelvis, and limbs. Disruption of sensory pathways and impairment of motor control after iSCI complicates this complex process, resulting in impaired balance, increased risk of falls, and decreased quality of life. While traditional rehabilitation methods strive to address these challenges, they often fail to target the specific complexities of turning dynamics.
Robotic exoskeletons are wearable devices designed to enhance mobility for iSCI patients. These innovative technologies are expected to enhance sensorimotor performance by providing external support, promoting gait symmetry, and promoting neuroplasticity through intensive training. Exoskeleton-assisted therapy has the potential not only to restore physical function, but also to promote psychosocial well-being, allowing individuals to participate more fully in daily activities and social interactions.
However, despite the growing body of research demonstrating the benefits of exoskeleton training, its efficacy in improving turning-while-walking performance among individuals with iSCI remains uncertain. Furthermore, the neurological mechanisms underlying the response to exoskeleton training in this population warrant deeper investigation.
This study aims to elucidate the effectiveness of a robotic exoskeleton on sensorimotor performance in subjects with iSCI. By filling gaps in the existing literature through rigorous methodology and comprehensive evaluation, investigators strive to provide valuable insights into the potential of exoskeleton-assisted therapy to optimize rehabilitation outcomes and improve the lives of iSCI survivors. Through a multidimensional approach encompassing both physical and psychosocial domains, this research seeks to pave the way for more tailored and effective interventions in SCI rehabilitation, ultimately fostering greater independence and well-being for those affected by this debilitating condition.
The objective of the cluster randomized controlled trial is to investigate the effectiveness of exoskeleton training specifically on turning-while-walking performance, balance control, gait function, muscle strength, spasticity, quality of life, self-efficacy, and fall incidence in people with iSCI. Moreover, the study will also explore how exoskeleton training may promote neuroplasticity and its relationship with ambulatory function and balance control changes in people with iSCI. The three centers will serve as distinct clusters and will be randomized into three groups: 1) Exoskeleton Training Group (ETG), 2) Conventional Exercise Group (CEG), and 3) Usual Care Control Group (UCG). The ETG and CTG will undergo 24 training sessions over 12 weeks respectively, and the UCG will receive standard care.
Assessments will be conducted at baseline, midpoint (Week 6), post-intervention (Week 12), and one-month post-intervention to evaluate outcomes such as turning-while-walking performance, balance control, gait performance, muscle strength, spasticity, self-efficacy, fall incidence, and quality of life. Additionally, cortical activity will be measured to explore changes in neural pathways and their correlation with turning performance and balance control during ambulation.
- Conditions
- Spinal Cord Injuries
- Being tested
- Exoskeleton Training, Conventional Physical Therapy
- Keywords
- Exoskeleton training, Balance, Turning, Gait, Neuroplasticity, Quality of life
- Medical subject headings
- Spinal Cord Injuries
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Exoskeleton TrainingDevice
Using EksoNR to train balance control and walking and turning abilities in patients with incomplete spinal cord injury.
Conventional Physical TherapyOther
Using conventional physical therapy methods to train the balance control and walking and turning abilities in patients with incomplete spinal cord injury.
| Study group | Role | What they receive |
|---|---|---|
| Exoskeleton Training Group | Experimental | EksoNR robotic training includes 10 min warm-up, and 5 min cool down (2x/wk, 12 weeks, 24 sessions), minimum 300 steps per session after the third session. The 45 min training excludes set-up/donning/doffing time and includes standing/up time, walking time, and seated rest breaks. The EksoNR training includes weight shift, stepping, straight walking with symmetry gait pattern, and turning with asymmetry gait pattern. Receives: Device: Exoskeleton Training |
| Conventional Training Group | Active comparator | Participants in this group will receive 24-session conventional physical therapy (2x/wk, 12 weeks). Each session lasts 60 minutes, including 10 min warm-up, and 5 min cool-down. Conventional training includes mobilization exercises, strengthening exercises, and balance and gait training. The sessions will be supervised by a trained physiotherapist who will provide guidance and cues to the participants throughout. EksoNR training sessions will be provided after the completion of all the assessments. Receives: Other: Conventional Physical Therapy |
| Usual Care Group | No intervention | Participants in this group continue with daily activities as normal over 12 weeks. No new gait training, mobility therapy, or new medications related to the condition under study, will be commenced during the study period. Participants in this group come to the study sites for evaluations at baseline, 6 weeks, 12 weeks, and one-month follow-up. EksoNR training sessions will be provided after the completion of all the assessments. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Duration of a turn
The participants are asked to walk a straight line of 1 meter, execute a 180-degree turn, and return to the starting position as quickly and safely as possible. Participants have the flexibility to use any necessary walking aids and wear their ankle-foot orthotics as needed. A turn is defined as starting and completing a 180-degree change in walking direction at a marked turn spot on the floor. The start of the turn is determined as the last foot contact prior to the inanition of the direction change. The end of the turn is determined as the last foot contact when both feet turn in the backward direction. Two tripod-mounted video cameras are placed in sagittal plane and frontal plane respectively.
An assessor will view the videotapes of the turn by using a video-cassette player. The duration of a turn will be extracted and computed averages of three trials on each side.
Measured: baseline, session 12 (6 Weeks), session 24 (12 Weeks), 1-month follow-up
Number of steps to a turn
The participants are asked to walk a straight line of 1 meter, execute a 180-degree turn, and return to the starting position as quickly and safely as possible. Participants have the flexibility to use any necessary walking aids and wear their ankle-foot orthotics as needed. A turn is defined as starting and completing a 180-degree change in walking direction at a marked turn spot on the floor. The start of the turn is determined as the last foot contact prior to the inanition of the direction change. The end of the turn is determined as the last foot contact when both feet turn in the backward direction. Two tripod-mounted video cameras are placed in sagittal plane and frontal plane respectively.
An assessor will view the videotapes of the turn by using a video-cassette player. The number of steps to a turn will be extracted and computed averages of three trials on each side.
Measured: baseline, session 12 (6 Weeks), session 24 (12 Weeks), 1-month follow-up
Secondary outcomes (13)
Limits of Stability (LOS)
The Limits of Stability (LOS) test assesses dynamic balance using the Biodex Medical System. Participants stand on a stable platform (level 12) with feet positioned to maintain balance over the center. The test measures the time and accuracy as participants lean to intercept eight targets displayed at 45° intervals around a central point representing their center of pressure. Each target is randomly highlighted, and participants must reach each target as quickly and accurately as possible, returning to the center between attempts. Targets are set at 50% of the LOS based on participant height, and practice trials precede the main test. Participants can use handles briefly for balance recovery, but excessive reliance on them will terminate the test. Key outcomes include the time taken to reach targets and directional control, calculated as a percentage of accuracy. Three trials are recorded, and averaged values are used for statistical analysis.
Measured: baseline, session 12 (6 Weeks), session 24 (12 Weeks), 1-month follow-up
Modified Clinical Test of Sensory Integration and Balance (m-CTSIB)
The Modified Clinical Test of Sensory Integration and Balance (m-CTSIB) is assessed using the Biodex Balance SD (Biodex Medical System, Inc., New York, USA). This test evaluates the effects of sensory integration on standing balance across four conditions: eyes open on a firm surface, eyes closed on a firm surface, eyes open on a foam surface, and eyes closed on a foam surface. Each condition lasts 30 seconds, with a minimum 10-second rest period between trials as needed. Participants complete practice trials prior to the test trials, and the order of testing is randomized to minimize learning effects. Balance performance is quantified using the Sway Index (SI), where a higher SI indicates greater instability. The SI is recorded for each condition, along with a final overall SI. Three trials are conducted for each condition, and averages of the individual conditions and overall SI are calculated for data analysis.
Measured: baseline, session 12 (6 Weeks), session 24 (12 Weeks), 1-month follow-up
Muscle strength
A hand-held dynamometer will assess the strength of bilateral lower limbs (hip flexors, extensors, abductors, adductors, knee flexors, extensors, ankle dorsiflexors, and plantarflexors) in a lying position, as well as trunk muscles (flexors, extensors, and rotators) in a sitting position. Each muscle strength test will be performed three times, and the averaged values will be used for data analysis.
Measured: baseline, session 12 (6 Weeks), session 24 (12 Weeks), 1-month follow-up
Modified Ashworth Scale (MAS)
The Modified Ashworth Scale (MAS) assesses spasticity in various muscles bilaterally, including hip flexors, extensors, adductors, knee flexors, extensors, and ankle dorsiflexors and plantarflexors. Scores range from 0 to 5, where 0 indicates no spasticity and 5 indicates severe spasticity. Higher scores reflect worse outcomes in terms of spasticity levels.
Measured: baseline, session 12 (6 Weeks), session 24 (12 Weeks), 1-month follow-up
Modified Functional Reaching Test (MFRT)
The Modified Functional Reaching Test (MFRT) will assess participants' balance while seated on a chair without back or arm support. A yardstick will be positioned at the level of the acromion, with participants' feet flat on the ground. Starting with one shoulder flexed to 90 degrees, the ulnar styloid process will be the anatomical landmark for measuring reach. Participants will reach forward, backward, and laterally as far as possible without trunk rotation, with a research team member providing safety support. The maximum distance reached in centimeters for each direction will be recorded. Each direction will be tested three times, and the average value for each direction will be used for data analysis.
Measured: baseline, session 12 (6 Weeks), session 24 (12 Weeks), 1-month follow-up
Berg Balance Scale (BBS)
The Berg Balance Scale (BBS) assesses functional mobility and balance through 14 tasks evaluating both static and dynamic balance. Each task is scored on a 5-point ordinal scale from 0 to 4, with 0 indicating the lowest level of function and 4 the highest. The total score ranges from 0 to 56, with higher scores indicating better balance and functional mobility. Scoring is based on the participant's ability to meet specific time or distance requirements and to perform tasks independently. Participants wear their usual shoes and any necessary orthotics during testing, but they are not allowed to use walking assistive devices.
Measured: baseline, session 12 (6 Weeks), session 24 (12 Weeks), 1-month follow-up
The Timed Up and Go Test (TUGT)
The Timed Up and Go Test (TUGT) is a test that involves various mobility activities that are common in daily life. When the test started, the subject should stand up from a seated position, walk straight forward for three meters, turn around, walk back to the starting position, and then sit down. The test will be repeated three times. The average time taken to complete the whole process will be used for data analysis.
Measured: baseline, session 12 (6 Weeks), session 24 (12 Weeks), 1-month follow-up
10 Meter Walk Test (10MWT)
10 Meter Walk Test (10MWT) is used to assess the walking speed of participants. Participants will be asked to walk at their maximum walking speed, with their usual walking aid if needed, for 10 meters. The initial and last two meters of the test will be allowed for acceleration and deceleration. The time required to walk for the intermediate six meters will be recorded. The average of three trials will be used for data analysis.
Measured: baseline, session 12 (6 Weeks), session 24 (12 Weeks), 1-month follow-up
Walking index for spinal cord injury (WISCI II)
The Walking Index for Spinal Cord Injury II (WISCI II) is used to classify participants' level of walking independence and the use of assistive devices or braces. This 20-item scale ranges from 0, indicating that the participant is unable to walk, to 20, which signifies that the participant can ambulate 10 meters without assistance, devices, or braces. Higher scores reflect greater walking independence.
Measured: baseline, session 12 (6 Weeks), session 24 (12 Weeks), 1-month follow-up
Fall incidence
Fall history will be assessed with a semi-structured interview by asking the participants about occurrence and frequency of falls during the last 12 month. A fall is defined as any fall, including a slip or a trip, in which the participant came to rest on the floor, ground, or on a lower level. All falls are recorded through weekly self-reports by participants, during the intervention and follow-up.
Measured: baseline, session 12 (6 Weeks), session 24 (12 Weeks), 1-month follow-up
The 36-Item Short Form Health Survey (SF-36)
The 36-Item Short Form Health Survey (SF-36) will be administered to participants to assess their quality of life. Participants will complete the survey, which consists of 36 questions covering eight health dimensions: physical functioning (PF), social functioning (SF), role physical (RP), role emotional (RE), mental health (MH), vitality (VT), bodily pain (BP), and general health (GH) perceptions. Responses will be scored on a standard 0 to 100 scale, where higher scores indicate better health-related quality of life (Forchheim et al., 2004). Data analysis will involve calculating overall total scores as well as individual scores for each dimension.
Measured: baseline, session 12 (6 Weeks), session 24 (12 Weeks), 1-month follow-up
Falls Efficacy Scale International (FES-I)
The Falls Efficacy Scale International (FES-I) is utilized to assess participants' concerns about falling during various daily activities. This scale comprises 16 items, each rated on a 4-point Likert scale from 1 (not at all concerned) to 4 (very concerned), resulting in a total score ranging from 16 (lowest concern) to 64 (highest concern), with higher scores indicating greater concern about falling. Thus, higher scores represent a worse outcome in terms of fall-related anxiety.
Measured: baseline, session 12 (6 Weeks), session 24 (12 Weeks), 1-month follow-up
Physical Activity Scale for Persons with Physical Disabilities (PASIPD)
The Physical Activity Scale for Persons with Physical Disabilities (PASIPD) is used to assess physical activity participation. his 13-item questionnaire quantifies the level of physical activity across leisure, household, and occupational activities over the past seven days. A total score is calculated for data analysis, with potential scores ranging from 0 (no physical activity) to higher values reflecting greater levels of activity.
Measured: baseline, session 12 (6 Weeks), session 24 (12 Weeks), 1-month follow-up
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted14 May 2025
- Study start1 Jun 2024
- Primary completion30 Nov 2025 (estimated)
- Study completion30 Nov 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Spinal Cord InjuriesStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- 1\) Exoskeleton training group, 2) conventional training group; 3) usual care group
- Masking
- Single blind
- Who is masked
- Investigator
- Enrolment
- 32 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Hong Kong Metropolitan University
- Sponsor type
- University, hospital or other
- Collaborators
- Nanjing Medical University
- Responsible party
- Sponsor
- Investigators
- William WN Tsang, PhD, Study chair, Department of Physiotherapy, School of Nursing and Health Studies, Hong Kong Metropolitan University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06971510
- Sponsor's protocol ID
- HE-OT2021/16
- Acronym
- iSCI
- Status last verified
- Dec 2024
- First submitted
- 28 May 2024
- Last updated
- 14 May 2025
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Chen M, Chan CW, Wang PY, Tsang WW. Effectiveness of exoskeleton training on turning-while-walking and balance control in subjects with incomplete spinal cord injury: protocol for a randomised clinical trial. BMJ Open. 2026 Feb 26;16(2):e112405. doi: 10.1136/bmjopen-2025-112405.
PubMed 41748185
Study at a glance
From the registry record, last updated by the sponsor on 14 May 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effectiveness of Robotic Exoskeleton on Sensori-motor Performance in Subjects With Incomplete Spinal Cord Injury: A Functional Near-Infrared Spectroscopy Study
- ClinicalTrials.gov ID
- NCT06971510
- Acronym / sponsor ID
- iSCI / HE-OT2021/16
- Conditions
- Spinal Cord Injuries
- Keywords
- Exoskeleton training, Balance, Turning, Gait, Neuroplasticity, Quality of life
- Study type
- Interventional
- Recruitment status
- Active, not recruiting
- Enrolment
- 32 participants (estimated)
- Lead sponsor
- Hong Kong Metropolitan UniversityUniversity, hospital or other
- Collaborators
- Nanjing Medical University
- Study start
- 1 Jun 2024 (actual)
- Primary completion
- 30 Nov 2025 (estimated)
- Study completion
- 30 Nov 2025 (estimated)
- First posted
- 14 May 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study investigates the impact of exoskeleton training on individuals with incomplete spinal cord injury (iSCI). Investigators focus on assessing how the use of the exoskeleton influences balance control and turning during ambulation and quality of life in this population. The study mainly involves interventions with participants utilizing exoskeleton devices to explore the influence on mobility, stability, and neuroplasticity, providing new insights into the potential benefits of exoskeleton training for individuals with incomplete spinal cord injuries.
Detailed description
Spinal cord injury (SCI) poses profound challenges to individuals, disrupting complex neural pathways responsible for motor and sensory functions. Across a spectrum of impairments, the ability to navigate and maneuver during walking, particularly turning, is a significant obstacle for patients with incomplete SCI (iSCI). Despite advances in rehabilitation strategies, turning-while-walking remains a biomechanically demanding task that is often overlooked in traditional interventions that focus primarily on linear gait training.
Turning-while-walking requires coordinated movements of the head, trunk, pelvis, and limbs. Disruption of sensory pathways and impairment of motor control after iSCI complicates this complex process, resulting in impaired balance, increased risk of falls, and decreased quality of life. While traditional rehabilitation methods strive to address these challenges, they often fail to target the specific complexities of turning dynamics.
Robotic exoskeletons are wearable devices designed to enhance mobility for iSCI patients. These innovative technologies are expected to enhance sensorimotor performance by providing external support, promoting gait symmetry, and promoting neuroplasticity through intensive training. Exoskeleton-assisted therapy has the potential not only to restore physical function, but also to promote psychosocial well-being, allowing individuals to participate more fully in daily activities and social interactions.
However, despite the growing body of research demonstrating the benefits of exoskeleton training, its efficacy in improving turning-while-walking performance among individuals with iSCI remains uncertain. Furthermore, the neurological mechanisms underlying the response to exoskeleton training in this population warrant deeper investigation.
This study aims to elucidate the effectiveness of a robotic exoskeleton on sensorimotor performance in subjects with iSCI. By filling gaps in the existing literature through rigorous methodology and comprehensive evaluation, investigators strive to provide valuable insights into the potential of exoskeleton-assisted therapy to optimize rehabilitation outcomes and improve the lives of iSCI survivors. Through a multidimensional approach encompassing both physical and psychosocial domains, this research seeks to pave the way for more tailored and effective interventions in SCI rehabilitation, ultimately fostering greater independence and well-being for those affected by this debilitating condition.
The objective of the cluster randomized controlled trial is to investigate the effectiveness of exoskeleton training specifically on turning-while-walking performance, balance control, gait function, muscle strength, spasticity, quality of life, self-efficacy, and fall incidence in people with iSCI. Moreover, the study will also explore how exoskeleton training may promote neuroplasticity and its relationship with ambulatory function and balance control changes in people with iSCI. The three centers will serve as distinct clusters and will be randomized into three groups: 1) Exoskeleton Training Group (ETG), 2) Conventional Exercise Group (CEG), and 3) Usual Care Control Group (UCG). The ETG and CTG will undergo 24 training sessions over 12 weeks respectively, and the UCG will receive standard care.
Assessments will be conducted at baseline, midpoint (Week 6), post-intervention (Week 12), and one-month post-intervention to evaluate outcomes such as turning-while-walking performance, balance control, gait performance, muscle strength, spasticity, self-efficacy, fall incidence, and quality of life. Additionally, cortical activity will be measured to explore changes in neural pathways and their correlation with turning performance and balance control during ambulation.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (investigator)
- Number of arms
- 3
- Model description
- 1) Exoskeleton training group, 2) conventional training group; 3) usual care group
| Arm | Type | Receives |
|---|---|---|
| Exoskeleton Training Group | Experimental | Device: Exoskeleton TrainingEksoNR robotic training includes 10 min warm-up, and 5 min cool down (2x/wk, 12 weeks, 24 sessions), minimum 300 steps per session after the third session. The 45 min training excludes set-up/donning/doffing time and includes standing/up time, walking time, and seated rest breaks. The EksoNR training includes weight shift, stepping, straight walking with symmetry gait pattern, and turning with asymmetry gait pattern. |
| Conventional Training Group | Active comparator | Other: Conventional Physical TherapyParticipants in this group will receive 24-session conventional physical therapy (2x/wk, 12 weeks). Each session lasts 60 minutes, including 10 min warm-up, and 5 min cool-down. Conventional training includes mobilization exercises, strengthening exercises, and balance and gait training. The sessions will be supervised by a trained physiotherapist who will provide guidance and cues to the participants throughout. EksoNR training sessions will be provided after the completion of all the assessments. |
| Usual Care Group | No intervention | –Participants in this group continue with daily activities as normal over 12 weeks. No new gait training, mobility therapy, or new medications related to the condition under study, will be commenced during the study period. Participants in this group come to the study sites for evaluations at baseline, 6 weeks, 12 weeks, and one-month follow-up. EksoNR training sessions will be provided after the completion of all the assessments. |
Who may qualify
- Ages
- 18 to 65 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (12 listed)
- Aged 18-65 years
- Traumatic or non-traumatic SCI, > 6 months since SCI onset Motor incomplete SCI (American Spinal Injury Association Impairment Scale, AIS C and D), neurologic level of injury (NLI) between C1-L2 (inclusive), as determined by the International Standards for Neurological Classification of SCI (ISNCSCI)
- Able to walk with or without walking aid independently for at least 2 meters
- No current or history of other neurological conditions
- Community-dwelling or living in a rehabilitation facility
Key exclusion criteria (11 listed)
- AIS-A SCI or AIS-B SCI
- Have been trained in exoskeleton or other robotic device for locomotor training within the past 4 months except for one or two training/demonstration sessions
- Currently involved in another intervention study
- Any medical issue that precludes full weight-bearing locomotor training including but not limited to:
- Spinal instability (or spinal orthotic unless cleared by physician) Acute deep vein thrombosis (DVT) with activity restrictions Severe, recurrent autonomic dysreflexia (AD) requiring medical intervention Heterotopic ossification (HO) in the lower extremities resulting in ROM restrictions at the hips or knees Two or more pathological fractures in the last 48 months in a major weight-bearing bone (femur or tibia) in the lower extremity Hip subluxation (x-rays will be obtained for individuals injured prior to 10 years of age)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Exoskeleton TrainingUsing EksoNR to train balance control and walking and turning abilities in patients with incomplete spinal cord injury. | Device | Exoskeleton Training Group |
| Conventional Physical TherapyUsing conventional physical therapy methods to train the balance control and walking and turning abilities in patients with incomplete spinal cord injury. | Other | Conventional Training Group |
Primary outcome
Duration of a turn
Time frame: baseline, session 12 (6 Weeks), session 24 (12 Weeks), 1-month follow-up
The participants are asked to walk a straight line of 1 meter, execute a 180-degree turn, and return to the starting position as quickly and safely as possible. Participants have the flexibility to use any necessary walking aids and wear their ankle-foot orthotics as needed. A turn is defined as starting and completing a 180-degree change in walking direction at a marked turn spot on the floor. The start of the turn is determined as the last foot contact prior to the inanition of the direction change. The end of the turn is determined as the last foot contact when both feet turn in the backward direction. Two tripod-mounted video cameras are placed in sagittal plane and frontal plane respectively. An assessor will view the videotapes of the turn by using a video-cassette player. The duration of a turn will be extracted and computed averages of three trials on each side.
Number of steps to a turn
Time frame: baseline, session 12 (6 Weeks), session 24 (12 Weeks), 1-month follow-up
The participants are asked to walk a straight line of 1 meter, execute a 180-degree turn, and return to the starting position as quickly and safely as possible. Participants have the flexibility to use any necessary walking aids and wear their ankle-foot orthotics as needed. A turn is defined as starting and completing a 180-degree change in walking direction at a marked turn spot on the floor. The start of the turn is determined as the last foot contact prior to the inanition of the direction change. The end of the turn is determined as the last foot contact when both feet turn in the backward direction. Two tripod-mounted video cameras are placed in sagittal plane and frontal plane respectively. An assessor will view the videotapes of the turn by using a video-cassette player. The number of steps to a turn will be extracted and computed averages of three trials on each side.
13 secondary outcomes
Limits of Stability (LOS)
Time frame: baseline, session 12 (6 Weeks), session 24 (12 Weeks), 1-month follow-up
Modified Clinical Test of Sensory Integration and Balance (m-CTSIB)
Time frame: baseline, session 12 (6 Weeks), session 24 (12 Weeks), 1-month follow-up
Muscle strength
Time frame: baseline, session 12 (6 Weeks), session 24 (12 Weeks), 1-month follow-up
Modified Ashworth Scale (MAS)
Time frame: baseline, session 12 (6 Weeks), session 24 (12 Weeks), 1-month follow-up
Modified Functional Reaching Test (MFRT)
Time frame: baseline, session 12 (6 Weeks), session 24 (12 Weeks), 1-month follow-up
Berg Balance Scale (BBS)
Time frame: baseline, session 12 (6 Weeks), session 24 (12 Weeks), 1-month follow-up
The Timed Up and Go Test (TUGT)
Time frame: baseline, session 12 (6 Weeks), session 24 (12 Weeks), 1-month follow-up
10 Meter Walk Test (10MWT)
Time frame: baseline, session 12 (6 Weeks), session 24 (12 Weeks), 1-month follow-up
Walking index for spinal cord injury (WISCI II)
Time frame: baseline, session 12 (6 Weeks), session 24 (12 Weeks), 1-month follow-up
Fall incidence
Time frame: baseline, session 12 (6 Weeks), session 24 (12 Weeks), 1-month follow-up
The 36-Item Short Form Health Survey (SF-36)
Time frame: baseline, session 12 (6 Weeks), session 24 (12 Weeks), 1-month follow-up
Falls Efficacy Scale International (FES-I)
Time frame: baseline, session 12 (6 Weeks), session 24 (12 Weeks), 1-month follow-up
Physical Activity Scale for Persons with Physical Disabilities (PASIPD)
Time frame: baseline, session 12 (6 Weeks), session 24 (12 Weeks), 1-month follow-up
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 14 May 2025.
- Derived from this study: PubMed 41748185Chen M, Chan CW, Wang PY, Tsang WW. Effectiveness of exoskeleton training on turning-while-walking and balance control in subjects with incomplete spinal cord injury: protocol for a randomised clinical trial. BMJ Open. 2026 Feb 26;16(2):e112405. doi: 10.1136/bmjopen-2025-112405.
- Individual participant dataSharing planned: No
Related trials for Spinal Cord Injuries
Recruiting
MyHand-SCI: An Active Hand Orthosis for Spinal Cord Injury
Spinal Cord Injuries, Tetraplegia
Recruiting
Clinical Outcome Assessment for AT & BCI
Spinal Cord Injury, ALS (Amyotrophic Lateral Sclerosis)
Recruiting
Transcutaneous Spinal Cord Stimulation Combined With 4-Aminopyridine and Intensive Rehabilitation in SCI
Spinal Cord Injuries
Not yet recruiting
Evaluating the Effect of the Zeen Mobility Device on Clinical Practicality, Safety, and Impact (Via Assessments of Walking, Standing Tolerance, Balance, Endurance, Effort, and Participation in Daily Tasks) in an Outpatient Rehabilitation Setting for Individuals With Mobility Impairments.
Stroke, Parkinson's Disease (PD)
RecruitingPhase 3
A Trial Investigating the Efficacy and Safety of NVG-291 in Subjects With Chronic Spinal Cord Injury
Chronic Spinal Cord Injury
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
William WN Tsang, PhD study chair
Department of Physiotherapy, School of Nursing and Health Studies, Hong Kong Metropolitan University
3 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Exoskeleton Training and Conventional Physical Therapy in people with Spinal Cord Injuries, run by Hong Kong Metropolitan University at 3 sites in China.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 12 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: under way, not looking for participants, as of the sponsor's last update on 14 May 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 3 sites in China. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Duration of a turn (time frame: baseline, session 12 (6 Weeks), session 24 (12 Weeks), 1-month follow-up). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06971510, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 May 2025.